PureTech Health Company Insiders

PRTC Stock  USD 16.64  0.35  2.06%   
PureTech Health employs about 56 people. The company is managed by 24 executives with a total tenure of roughly 131 years, averaging almost 5.0 years of service per executive, having 2.33 employees per reported executive. Evaluation of PureTech Health's management performance can provide insight into the firm performance.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

PureTech Health Management Team Effectiveness

The company has return on total asset (ROA) of (0.1295) % which means that it has lost $0.1295 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0944 %, meaning that it created $0.0944 on every $100 dollars invested by stockholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities.

PureTech Health Workforce Comparison

PureTech Health PLC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,026. PureTech Health holds roughly 56.0 in number of employees claiming about 2.76% of equities under Health Care industry.
The company has Profit Margin (PM) of 7.93 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (25.9) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $25.9.

PureTech Health PLC Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. PureTech Health PLC Price Series Summation is a cross summation of PureTech Health price series and its benchmark/peer.

PureTech Health Notable Stakeholders

A PureTech Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PureTech Health often face trade-offs trying to please all of them. PureTech Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PureTech Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daphne ZoharSenior FounderProfile
Eric ElenkoCoFounder PresidentProfile
Dr JDSecretary, PresidentProfile
Dr LangerCoFounder DirectorProfile
Frank SalisburySenior StrategyProfile
Michael ChenChief SeaportProfile
Anita JDSenior PropertyProfile
Lauren MBAChief OfficerProfile
RDN MSChief OfficerProfile
David ElmalehCoFounder AdvisorProfile
Spencer BallExecutive ResourcesProfile
III JDGeneral SecretaryProfile
Joseph BolenChief OfficerProfile
Aleksandra MDHead OncologyProfile
Kana DeLucaAssociate RelationsProfile
William CPAControllerProfile
Eric MBAChief OfficerProfile
Dilip KodiraHead ScienceProfile
Allison TalbotSenior RelationsProfile
Bennett MDCoFounder AdvisorProfile
Cheryl MurphyHead StrategyProfile
Robert JDInterim OfficerProfile
MPH MDSenior AffairsProfile

About PureTech Health Management Performance

The success or failure of an entity such as PureTech Health PLC often depends on how effective the management is. PureTech Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PureTech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PureTech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PureTech Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
Please note, the presentation of PureTech Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.

PureTech Health Workforce Analysis

Traditionally, organizations such as PureTech Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PureTech Health within its industry.

PureTech Health Manpower Efficiency

Return on PureTech Health Manpower

Revenue Per Employee86.2K
Revenue Per Executive201.2K
Net Income Per Employee496.1K
Net Income Per Executive1.2M
Working Capital Per Employee6.2M
Working Capital Per Executive14.4M

Complementary Tools for PureTech Stock analysis

When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm